Your browser doesn't support javascript.
loading
Transcriptional Heterogeneity Overcomes Super-Enhancer Disrupting Drug Combinations in Multiple Myeloma.
Welsh, Seth J; Barwick, Benjamin G; Meermeier, Erin W; Riggs, Daniel L; Shi, Chang-Xin; Zhu, Yuan Xiao; Sharik, Meaghen E; Du, Megan T; Abrego Rocha, Leslie D; Garbitt, Victoria M; Stein, Caleb K; Petit, Joachim L; Meurice, Nathalie; Tafoya Alvarado, Yuliza; Fonseca, Rodrigo; Todd, Kennedi T; Brown, Sochilt; Hammond, Zachery J; Cuc, Nicklus H; Wittenberg, Courtney; Herzog, Camille; Roschke, Anna V; Demchenko, Yulia N; Chen, Wei-Dong D; Li, Peng; Liao, Wei; Leonard, Warren J; Lonial, Sagar; Bahlis, Nizar J; Neri, Paola; Boise, Lawrence H; Chesi, Marta; Bergsagel, P Leif.
Afiliação
  • Welsh SJ; Department of Medicine, Division of Hematology/Oncology, Mayo Clinic, Scottsdale, Arizona.
  • Barwick BG; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia.
  • Meermeier EW; Department of Medicine, Division of Hematology/Oncology, Mayo Clinic, Scottsdale, Arizona.
  • Riggs DL; Department of Medicine, Division of Hematology/Oncology, Mayo Clinic, Scottsdale, Arizona.
  • Shi CX; Department of Medicine, Division of Hematology/Oncology, Mayo Clinic, Scottsdale, Arizona.
  • Zhu YX; Department of Medicine, Division of Hematology/Oncology, Mayo Clinic, Scottsdale, Arizona.
  • Sharik ME; Department of Medicine, Division of Hematology/Oncology, Mayo Clinic, Scottsdale, Arizona.
  • Du MT; Department of Medicine, Division of Hematology/Oncology, Mayo Clinic, Scottsdale, Arizona.
  • Abrego Rocha LD; Department of Medicine, Division of Hematology/Oncology, Mayo Clinic, Scottsdale, Arizona.
  • Garbitt VM; Department of Medicine, Division of Hematology/Oncology, Mayo Clinic, Scottsdale, Arizona.
  • Stein CK; Department of Medicine, Division of Hematology/Oncology, Mayo Clinic, Scottsdale, Arizona.
  • Petit JL; Department of Medicine, Division of Hematology/Oncology, Mayo Clinic, Scottsdale, Arizona.
  • Meurice N; Department of Medicine, Division of Hematology/Oncology, Mayo Clinic, Scottsdale, Arizona.
  • Tafoya Alvarado Y; Department of Medicine, Division of Hematology/Oncology, Mayo Clinic, Scottsdale, Arizona.
  • Fonseca R; Department of Medicine, Division of Hematology/Oncology, Mayo Clinic, Scottsdale, Arizona.
  • Todd KT; Department of Medicine, Division of Hematology/Oncology, Mayo Clinic, Scottsdale, Arizona.
  • Brown S; Department of Medicine, Division of Hematology/Oncology, Mayo Clinic, Scottsdale, Arizona.
  • Hammond ZJ; Department of Medicine, Division of Hematology/Oncology, Mayo Clinic, Scottsdale, Arizona.
  • Cuc NH; Department of Medicine, Division of Hematology/Oncology, Mayo Clinic, Scottsdale, Arizona.
  • Wittenberg C; Department of Medicine, Division of Hematology/Oncology, Mayo Clinic, Scottsdale, Arizona.
  • Herzog C; Department of Medicine, Division of Hematology/Oncology, Mayo Clinic, Scottsdale, Arizona.
  • Roschke AV; Genetics Branch, Center for Cancer Research, NCI, Bethesda, Maryland.
  • Demchenko YN; Genetics Branch, Center for Cancer Research, NCI, Bethesda, Maryland.
  • Chen WD; Genetics Branch, Center for Cancer Research, NCI, Bethesda, Maryland.
  • Li P; Laboratory of Molecular Immunology and the Immunology Center, National Heart, Lung and Blood Institute, NIH, Bethesda, Maryland.
  • Liao W; Laboratory of Molecular Immunology and the Immunology Center, National Heart, Lung and Blood Institute, NIH, Bethesda, Maryland.
  • Leonard WJ; Laboratory of Molecular Immunology and the Immunology Center, National Heart, Lung and Blood Institute, NIH, Bethesda, Maryland.
  • Lonial S; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia.
  • Bahlis NJ; Department of Medical Oncology and Hematology, Tom Baker Cancer Center, Calgary, Canada.
  • Neri P; Charbonneau Cancer Research Institute, University of Calgary, Calgary, Canada.
  • Boise LH; Department of Medical Oncology and Hematology, Tom Baker Cancer Center, Calgary, Canada.
  • Chesi M; Charbonneau Cancer Research Institute, University of Calgary, Calgary, Canada.
  • Bergsagel PL; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia.
Blood Cancer Discov ; 5(1): 34-55, 2024 01 08.
Article em En | MEDLINE | ID: mdl-37767768
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Blood Cancer Discov Ano de publicação: 2024 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Blood Cancer Discov Ano de publicação: 2024 Tipo de documento: Article País de publicação: Estados Unidos